Institutional members access full text with Ovid®

Is Tailoring Treatment of Rectal Cancer the Only True Benefit of Long-Course Neoadjuvant Chemoradiation?

Habr-Gama, Angelita M.D., Ph.D.1,2; Gama-Rodrigues, Joaquim M.D., Ph.D.1,2; Perez, Rodrigo Oliva M.D., Ph.D.1,3

doi: 10.1097/DCR.0b013e318277e8e4
For Debate